Many studies have shown that Chi3l1 is widely expressed in all regions of the human brain and serves as a diagnostic biomarker and therapeutic target for multiple brain-related inflammatory diseases (e.g., encephalitis, psychosis, multiple sclerosis, and brain injury) (Figure 1). This evidence concerns the gene CHI3L1 and multiple sclerosis.